Tarsus Pharmaceuticals (TARS) Q3 2023 Earnings

9NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.36
-1.07
-0.78
-0.49

Details

Expected EPS
-1.36
Actual EPS
-1.28
Surprise EPS
0.08
Surprise Percent
+5.88%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -1.28 per share for Q3 2023.

0 Comments

Share your thoughts